Do complications following pancreatic resections impact hospital costs in France: Medico-economic study on 127 patients

Summary Objective To define the cost of pancreatectomies and to identify factors associated with increased hospital costs after pancreatic resection. Methods All patients undergoing pancreatic surgery in our department between January 2008 and December 2014 were included. All complications occurring during hospitalization or in the 90-day period after discharge were documented. The hospital costs were analyzed and predictive factors of increased hospital costs were determined. Results One hundred and twenty seven patients were identified. Most patients underwent pancreatectomy for malignant tumors (70%). Median hospital costs were 21,392 [15,998–29,667] euros. Age ( P  = 0.011) and preoperative jaundice ( P P  = 0.001 and P  = 0.002, respectively). Pancreatoduodenectomy was associated with statistically significantly higher costs compared to distal pancreatectomy (21,770 vs. 15,422 euros, P  = 0.001). Severe postoperative complications (Clavien-Dindo grade ≥ 3) ( P  = 0.001), septic complications ( P  = 0.002) and hemorrhage ( P  = 0.001) statistically significantly increased costs. In multivariate analysis, septic ( P  = 0.003) and severe complications ( P  = 0.01) were statistically significantly associated with increased hospital costs. Conclusion Pancreatic surgery is associated with high hospital costs, essentially related to postoperative complications.